600161 天坛生物
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额338,747819,7812,393,5761,126,002980,350
投资活动产生之现金流量净额124,355(1,859,116)(1,246,907)(1,870,901)(2,184,964)
筹资活动产生之现金流量净额(442,396)(370,287)(508,084)(378,202)2,774,371
汇率变动对现金及现金等价物的影响(29)(44)0(48)(11)
现金及现金等价物净增加/(减少)20,677(1,409,666)638,585(1,123,149)1,569,747
期初现金及现金等价物余额1,422,9212,832,5872,194,0023,317,1511,747,405
期末现金及现金等价物余额1,443,5981,422,9212,832,5872,194,0023,317,151